Narrow band UVB therapy versus tazarotene and narrow band UVB combination therapy in psoriasis: a comparative study
Keywords:Narrow band UVB, Psoriasis, Tazarotene
Background: Narrow band UVB phototherapy (NBUVB) is considered one of the most effective therapeutic modalities for patients with psoriasis. The long term side effects of narrowband UVB therapy have not been fully documented. There has been a great deal of interest in photo combination therapies that are capable of both reducing cumulative UVB doses and accelerating resolution of skin lesions. The aim of our study was to compare the efficacy and tolerability of NBUVB plus tazarotene combination therapy with NBUVB mono therapy.
Methods: Forty patients with chronic plaque type psoriasis were taken up for the study and were randomly divided into two groups of 20 each. One group was treated with thrice-weekly NBUVB phototherapy and the other group received NBUVB phototherapy thrice weekly in addition to topical tazarotene once daily at bed time.
Results: In the tazarotene combination group, the reduction in PASI score was more rapid. The duration of treatment and the mean cumulative dose of NBUVB was lesser in the tazarotene combination group. Irritation due to tazarotene was mild and combination of tazarotene with NBUVB was well tolerated.
Conclusions: We concluded that combination of tazarotene with NBUVB was well tolerated and was significantly more effective than NBUVB phototherapy alone.
Rai R, Srinivas CR. Phototherapy: An Indian perceptive. Indian J Dermatol. 2007;52(4):169-75.
Kist JM, Abby S. Van Voorhees. Narrowband ultraviolet B therapy for psoriasis and other skin disorders. Advances Dermatology. 2005;21:235-6.
Dawe RS. A quantitative review of studies comparing the efficacy of narrow band and broad band ultraviolet B for psoriasis. Br J Dermatol. 2003;149:669-72.
Weinstein GD, Krueger GG, Lowe NJ, Duvic M, Friedman DJ, Jegasothy BV, et al. Tazarotene Gel, a new retinoid, for topical therapy of psoriasis:vehicle-controlled study of safety, efficacy and duration of therapeutic effect. J Am Acad Dermatol. 1997;37:85-92.
Marks R. Clinical safety of Tazarotene in the treatment of plaque psoriasis. J Am Acad Dermatol. 1997;37:25-32.
Menter MA, See JA, Amend WJ, Ellis CN, Krueger GG, Lebwohl M, et al. Proceedings of the Psoriasis Combination and Rotation Therapy conference. Deer Valley, Utah,Oct.7-9,1994. J Am Acad Dermatol.1996;34:315-21.
Koo JYM, Lowe Nj, Lew-Kaya DA, Vasilopoulos AI, Lue JC, Sefton J, et al. Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol. 2000;43:821-8.
Behrens S, Grundman-Kollman M, Schiener R, Peter RU, Kerscher M. Combination therapy of psoriasis with narrowband UVB irradiation and topical tazarotene gel. J Am Acad Dermatol. 2000;42:493-5.
Young AR, Walker SL. Acute and chronic effects of ultraviolet radiation on the skin. In: Fitzpatrick’s Dermatology in general medicine. 7th edition. 2008: 809-15.